Cullinan Therapeutics (NASDAQ: CGEM) net income
Cullinan Therapeutics reported a net loss of $219.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $167.4m.
Cullinan Therapeutics's best year of the last 6 was fiscal 2022. It reported a loss in 5 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$219.9m | — | — | — |
| 2024 | −$167.4m | — | — | — |
| 2023 | −$153.2m | −237.7% | — | −$3.69 |
| 2022 | $111.2m | — | — | $2.46 |
| 2021 | −$65.6m | — | −346.1% | −$1.52 |
| 2020 | −$51.8m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Cullinan Therapeutics net income compared with its sector
By net income for its latest fiscal year, Cullinan Therapeutics ranks 420th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 418th | Disc Medicine | −$212.2m | — |
| 419th | Immunome | −$212.4m | −3,060.0% |
| 420th | Cullinan Therapeutics | −$219.9m | — |
| 421st | Vanda Pharmaceuticals | −$220.5m | −102.0% |
| 422nd | Phathom Pharmaceuticals | −$221.2m | −126.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Cullinan Therapeutics
- How much did Cullinan Therapeutics earn in fiscal 2025?
- Cullinan Therapeutics reported a net loss of $219.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $167.4m.
- What was the most profitable year for Cullinan Therapeutics?
- Of its last 6 fiscal years, fiscal 2022, with $111.2m.
- Where does Cullinan Therapeutics rank in its sector by net income?
- It ranks 420th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Cullinan Therapeutics come from?
- From the annual report (Form 10-K) that Cullinan Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Cullinan Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Cullinan Therapeutics: the Cullinan Therapeutics page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.